Sneak peak of AACR II 2020

Dr. Elaine Mardis and Dr. Antoni Ribas offer a sneak peek of the AACR annual meeting II and its hundreds of talks and thousands of posters. And they share their thoughts on the pros and cons of virtual conferences. Episode art: Justin Jackson
Part I of the annual meeting of the American Association for Cancer Research—it was all virtual—had 61,000 attendees. Part II is about to start. Here’s a sneak peek about the meeting, its hundreds of talks and thousands of posters. Virtual conferences mean less of a carbon footprint, maybe a broader reach and a chance for attendees who cannot typically travel to AACR to attend virtually. 
 
Commenting on AACR II and about virtual conferences more generally: 
Dr. Elaine Mardis: the current president of the American Association for Cancer Research. She is co-Executive Director of the Institute for Genomic Medicine at Nationwide Children’s Hospital and the Nationwide Foundation Endowed Chair in Genomic Medicine. 
And Dr. Antoni Ribas, the incoming AACR president. He is at the University of California Los Angeles. He directs the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center and is director of the Parker Institute for Cancer Immunotherapy Center at UCLA.